Literature DB >> 16466528

The foetal Leydig cell-- differentiation, function and regulation.

P J O'Shaughnessy1, P J Baker, H Johnston.   

Abstract

The foetal Leydig cell population arises shortly after testicular differentiation at around 12.5 dpc in the mouse and 6 weeks in the human. These cells function, primarily, to produce androgens which are essential for masculinization of the foetus. The origin of the foetal Leydig cells remains uncertain but it has been suggested that adrenocortical cells and foetal Leydig cells may share a common origin in an adreno-genital primordium. Studies in the mouse are beginning to identify factors such as desert hedgehog and platelet-derived growth factor which are required for foetal Leydig cell development. Regulation of foetal Leydig cell function remains uncertain in most species. Unlike the adult population of Leydig cells, the foetal Leydig cells in the mouse do not require luteinizing hormone (LH) to stimulate androgen production. An intact pituitary does appear to be required, however, and adrenocorticotrophic hormone (ACTH) will stimulate foetal Leydig cell function directly suggesting that both LH and ACTH act to maintain Leydig cell function in vivo. In the human LH/hCG is required for foetal Leydig cell function although the cells may also be sensitive to ACTH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466528     DOI: 10.1111/j.1365-2605.2005.00555.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  35 in total

1.  Spatial ability and prenatal androgens: meta-analyses of congenital adrenal hyperplasia and digit ratio (2D:4D) studies.

Authors:  David A Puts; Michael A McDaniel; Cynthia L Jordan; S Marc Breedlove
Journal:  Arch Sex Behav       Date:  2008-02

2.  The PDGF signaling pathway controls multiple steroid-producing lineages.

Authors:  Jennifer Schmahl; Kamran Rizzolo; Philippe Soriano
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

3.  Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia.

Authors:  Shinichi Miyagawa; Yoshihiko Satoh; Ryuma Haraguchi; Kentaro Suzuki; Taisen Iguchi; Makoto M Taketo; Naomi Nakagata; Takahiro Matsumoto; Ken-ichi Takeyama; Shigeaki Kato; Gen Yamada
Journal:  Mol Endocrinol       Date:  2009-03-12

4.  Characterization of bovine fetal Leydig cells by KIT expression.

Authors:  Nikoloz Tsikolia; Claudia Merkwitz; Kristina Sass; Michiharu Sakurai; Katharina Spanel-Borowski; Albert Markus Ricken
Journal:  Histochem Cell Biol       Date:  2009-09-19       Impact factor: 4.304

5.  Wt1 dictates the fate of fetal and adult Leydig cells during development in the mouse testis.

Authors:  Qing Wen; Qiao-Song Zheng; Xi-Xia Li; Zhao-Yuan Hu; Fei Gao; C Yan Cheng; Yi-Xun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-21       Impact factor: 4.310

6.  Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment.

Authors:  Stefanie L Bronson; Tracy L Bale
Journal:  Endocrinology       Date:  2014-05-05       Impact factor: 4.736

Review 7.  Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice.

Authors:  Ruey-Sheng Wang; Shuyuan Yeh; Chii-Ruey Tzeng; Chawnshang Chang
Journal:  Endocr Rev       Date:  2009-01-27       Impact factor: 19.871

Review 8.  Endocrine disruptors and Leydig cell function.

Authors:  K Svechnikov; G Izzo; L Landreh; J Weisser; O Söder
Journal:  J Biomed Biotechnol       Date:  2010-08-25

Review 9.  Phthalate-induced testicular dysgenesis syndrome: Leydig cell influence.

Authors:  Guo-Xin Hu; Qing-Quan Lian; Ren-Shan Ge; Dianne O Hardy; Xiao-Kun Li
Journal:  Trends Endocrinol Metab       Date:  2009-03-09       Impact factor: 12.015

10.  Fetal Leydig Cells Persist as an Androgen-Independent Subpopulation in the Postnatal Testis.

Authors:  Yuichi Shima; Sawako Matsuzaki; Kanako Miyabayashi; Hiroyuki Otake; Takashi Baba; Shigeaki Kato; Ilpo Huhtaniemi; Ken-ichirou Morohashi
Journal:  Mol Endocrinol       Date:  2015-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.